http://bio2rdf.org/drugbank_resource:DB00176_DB00540_nanopub.RAw2bcuMit0yHGVGUmKeqBckOiXOfmQ18M5MjMwd8ttPA#head http://bio2rdf.org/drugbank_resource:DB00176_DB00540_nanopub.RAw2bcuMit0yHGVGUmKeqBckOiXOfmQ18M5MjMwd8ttPA http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00176_DB00540_nanopub.RAw2bcuMit0yHGVGUmKeqBckOiXOfmQ18M5MjMwd8ttPA#assertion http://bio2rdf.org/drugbank_resource:DB00176_DB00540_nanopub.RAw2bcuMit0yHGVGUmKeqBckOiXOfmQ18M5MjMwd8ttPA http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00176_DB00540_nanopub.RAw2bcuMit0yHGVGUmKeqBckOiXOfmQ18M5MjMwd8ttPA#provenance http://bio2rdf.org/drugbank_resource:DB00176_DB00540_nanopub.RAw2bcuMit0yHGVGUmKeqBckOiXOfmQ18M5MjMwd8ttPA http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00176_DB00540_nanopub.RAw2bcuMit0yHGVGUmKeqBckOiXOfmQ18M5MjMwd8ttPA#publicationInfo http://bio2rdf.org/drugbank_resource:DB00176_DB00540_nanopub.RAw2bcuMit0yHGVGUmKeqBckOiXOfmQ18M5MjMwd8ttPA http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00176_DB00540_nanopub.RAw2bcuMit0yHGVGUmKeqBckOiXOfmQ18M5MjMwd8ttPA#assertion http://bio2rdf.org/drugbank:DB00176 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00176_DB00540 http://bio2rdf.org/drugbank:DB00540 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00176_DB00540 http://bio2rdf.org/drugbank_resource:DB00176_DB00540 http://purl.org/dc/terms/identifier drugbank_resource:DB00176_DB00540 http://bio2rdf.org/drugbank_resource:DB00176_DB00540 http://purl.org/dc/terms/title DDI between Fluvoxamine and Nortriptyline - The SSRI, fluvoxamine, may increase the serum concentration of the tricyclic antidepressant, nortriptyline, by decreasing its metabolism. Additive modulation of serotonin activity also increases the risk of serotonin syndrome. Monitor for development of serotonin syndrome during concomitant therapy. Monitor for changes in the therapeutic and adverse effects of nortriptyline if fluvoxamine is initiated, discontinued or dose changed. http://bio2rdf.org/drugbank_resource:DB00176_DB00540 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00176_DB00540 http://www.w3.org/2000/01/rdf-schema#label DDI between Fluvoxamine and Nortriptyline - The SSRI, fluvoxamine, may increase the serum concentration of the tricyclic antidepressant, nortriptyline, by decreasing its metabolism. Additive modulation of serotonin activity also increases the risk of serotonin syndrome. Monitor for development of serotonin syndrome during concomitant therapy. Monitor for changes in the therapeutic and adverse effects of nortriptyline if fluvoxamine is initiated, discontinued or dose changed. [drugbank_resource:DB00176_DB00540] http://bio2rdf.org/drugbank_resource:DB00176_DB00540_nanopub.RAw2bcuMit0yHGVGUmKeqBckOiXOfmQ18M5MjMwd8ttPA#provenance http://bio2rdf.org/drugbank_resource:DB00176_DB00540_nanopub.RAw2bcuMit0yHGVGUmKeqBckOiXOfmQ18M5MjMwd8ttPA#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00176_DB00540_nanopub.RAw2bcuMit0yHGVGUmKeqBckOiXOfmQ18M5MjMwd8ttPA#publicationInfo http://bio2rdf.org/drugbank_resource:DB00176_DB00540_nanopub.RAw2bcuMit0yHGVGUmKeqBckOiXOfmQ18M5MjMwd8ttPA#signature.MCwCFBpkWMi6ASBg http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00176_DB00540_nanopub.RAw2bcuMit0yHGVGUmKeqBckOiXOfmQ18M5MjMwd8ttPA#signature.MCwCFBpkWMi6ASBg http://purl.org/nanopub/x/hasSignature MCwCFBpkWMi6ASBg+l1PqfxPDtakzDIAAhRS0Wtk+c2SyUy6IjbXDJtg2enP2A== http://bio2rdf.org/drugbank_resource:DB00176_DB00540_nanopub.RAw2bcuMit0yHGVGUmKeqBckOiXOfmQ18M5MjMwd8ttPA#signature.MCwCFBpkWMi6ASBg http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00176_DB00540_nanopub.RAw2bcuMit0yHGVGUmKeqBckOiXOfmQ18M5MjMwd8ttPA http://purl.org/dc/terms/created 2018-03-30T11:12:46.861+02:00 http://bio2rdf.org/drugbank_resource:DB00176_DB00540_nanopub.RAw2bcuMit0yHGVGUmKeqBckOiXOfmQ18M5MjMwd8ttPA http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00176_DB00540_nanopub.RAw2bcuMit0yHGVGUmKeqBckOiXOfmQ18M5MjMwd8ttPA http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00176_DB00540_nanopub.RAw2bcuMit0yHGVGUmKeqBckOiXOfmQ18M5MjMwd8ttPA#signature.MCwCFBpkWMi6ASBg http://bio2rdf.org/drugbank_resource:DB00176_DB00540_nanopub.RAw2bcuMit0yHGVGUmKeqBckOiXOfmQ18M5MjMwd8ttPA http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234